These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 31821430

  • 1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM, Chaudhary K, Cho JH, Liang LW, Argulian E, Chan L, Dobbyn A, Guerraty MA, Judy R, Kay J, Kember RL, Levin MG, Saha A, Van Vleck T, Verma SS, Weaver J, Abul-Husn NS, Baras A, Chirinos JA, Drachman B, Kenny EE, Loos RJF, Narula J, Overton J, Reid J, Ritchie M, Sirugo G, Nadkarni G, Rader DJ, Do R.
    JAMA; 2019 Dec 10; 322(22):2191-2202. PubMed ID: 31821430
    [Abstract] [Full Text] [Related]

  • 2. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM, Damrauer SM, Tcheandjieu C, Erbe D, Aldinc E, Hawkins PN, Gillmore JD, Hull LE, Lynch JA, Joseph J, Ticau S, Flynn-Carroll AO, Deaton AM, Ward LD, Assimes TL, Tsao PS, Chang KM, Rader DJ, Fitzgerald K, Vaishnaw AK, Hinkle G, Nioi P.
    Sci Rep; 2021 Jun 02; 11(1):11645. PubMed ID: 34079032
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
    Haring B, Hunt RP, Shadyab AH, Eaton C, Kaplan R, Martin LW, Panjrath G, Kuller LH, Assimes T, Kooperberg C, Wassertheil-Smoller S.
    JACC Heart Fail; 2023 Sep 02; 11(9):1189-1199. PubMed ID: 36930136
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
    Kozlitina J, Garg S, Drazner MH, Matulevicius SA, Ayers C, Overton J, Reid J, Baras A, Rao K, Pandey A, Berry J, de Lemos JA, Grodin JL.
    J Card Fail; 2022 Mar 02; 28(3):403-414. PubMed ID: 34634447
    [Abstract] [Full Text] [Related]

  • 6. The amyloidogenic V122I transthyretin variant in elderly black Americans.
    Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, Butler KR, Boerwinkle E, Solomon SD.
    N Engl J Med; 2015 Jan 01; 372(1):21-9. PubMed ID: 25551524
    [Abstract] [Full Text] [Related]

  • 7. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB, Okafor HE, Farber-Eger EH, Wells QS.
    Am J Med; 2021 Feb 01; 134(2):e98-e100. PubMed ID: 32866461
    [Abstract] [Full Text] [Related]

  • 8. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL.
    JAMA Cardiol; 2017 Mar 01; 2(3):305-313. PubMed ID: 28196196
    [Abstract] [Full Text] [Related]

  • 9. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL.
    J Am Heart Assoc; 2023 Aug 01; 12(15):e028973. PubMed ID: 37486082
    [Abstract] [Full Text] [Related]

  • 10. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
    Jacobson D, Tagoe C, Schwartzbard A, Shah A, Koziol J, Buxbaum J.
    Am J Cardiol; 2011 Aug 01; 108(3):440-4. PubMed ID: 21600538
    [Abstract] [Full Text] [Related]

  • 11. Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Sinha A, Zheng Y, Nannini D, Qu Y, Hou L, Shah SJ, Yancy CW, McNally EM, Fornage M, Lima J, Lloyd-Jones DM, Rasmussen-Torvik LJ, Khan SS.
    JAMA Cardiol; 2021 Jun 01; 6(6):718-722. PubMed ID: 33355618
    [Abstract] [Full Text] [Related]

  • 12. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
    Dungu JN, Papadopoulou SA, Wykes K, Mahmood I, Marshall J, Valencia O, Fontana M, Whelan CJ, Gillmore JD, Hawkins PN, Anderson LJ.
    Circ Heart Fail; 2016 Sep 01; 9(9):. PubMed ID: 27618855
    [Abstract] [Full Text] [Related]

  • 13. Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I TTR carriers in the general population.
    Hendren NS, De Lemos JA, Berry JD, Kozlitina J, Saelices L, Ji AX, Shao Z, Liu CF, Garg S, Farr MA, Drazner MH, Tang WHW, Grodin JL.
    Amyloid; 2024 Jun 01; 31(2):124-131. PubMed ID: 38445629
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD.
    Eur J Heart Fail; 2023 Apr 01; 25(4):515-524. PubMed ID: 36644836
    [Abstract] [Full Text] [Related]

  • 15. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis.
    Prokaeva T, Klimtchuk ES, Feschenko P, Spencer B, Cui H, Burks EJ, Aslebagh R, Muneeruddin K, Shaffer SA, Varghese E, Berk JL, Connors LH.
    Amyloid; 2023 Jun 01; 30(2):141-152. PubMed ID: 36286264
    [Abstract] [Full Text] [Related]

  • 16. Prediction of Incident Heart Failure in TTR Val122Ile Carriers One Year Ahead of Diagnosis in a Multiethnic Biobank.
    Chaudhary K, Petrazzini BO, Narula J, Nadkarni GN, Do R.
    Am J Cardiol; 2021 Mar 01; 142():151-153. PubMed ID: 33333072
    [No Abstract] [Full Text] [Related]

  • 17. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
    Gentile L, Di Bella G, Minutoli F, Cucinotta F, Obici L, Mussinelli R, Arimatea I, Russo M, Toscano A, Vita G, Mazzeo A.
    J Peripher Nerv Syst; 2020 Sep 01; 25(3):273-278. PubMed ID: 32395865
    [Abstract] [Full Text] [Related]

  • 18. Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.
    Reddi HV, Jenkins S, Theis J, Thomas BC, Connors LH, Van Rhee F, Highsmith WE.
    J Mol Diagn; 2014 Jan 01; 16(1):68-74. PubMed ID: 24184229
    [Abstract] [Full Text] [Related]

  • 19. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M.
    Am Heart J; 2009 Oct 01; 158(4):607-14. PubMed ID: 19781421
    [Abstract] [Full Text] [Related]

  • 20. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D.
    Am Heart J; 2010 May 01; 159(5):864-70. PubMed ID: 20435197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.